Warrants (Details) - Warrants [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Number of Shares | ||
| Beginning Balance | 4,105,398 | 7,237,763 |
| Grants | 3,600,000 | 860,000 |
| Expiration | (2,015,020) | (3,992,365) |
| Ending Balance | 5,690,378 | 4,105,398 |
| Warrants exercisable | 5,690,378 | 4,105,398 |
| Weighted Average Exercise Price | ||
| Beginning Balance | $ 0.59 | $ 0.51 |
| Grants | 0.70 | 0.70 |
| Expirations | 0.69 | 0.46 |
| Ending Balance | 0.63 | 0.59 |
| Options exercisable | $ 0.63 | $ 0.59 |
| Weighted Average Remaining Contractual Life (years) | ||
| Beginning Balance | 1 year 9 months 14 days | 1 year 4 months 6 days |
| Grants | 5 years | 5 years |
| Expirations | ||
| Ending Balance | 3 years 8 months 19 days | 1 year 9 months 14 days |
| Aggregate Intrinsic Value | ||
| Beginning Balance | ||
| Expirations | ||
| Grants | ||
| Ending Balance | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. No definition available.
|
| X | ||||||||||
- Details
|